Amanote Research
Register
Sign In
Safety of the Novel Vector Vaccine Against Brucella Abortus Based on Recombinant Influenza Viruses Expressing Brucella L7/L12 and OMP16 Proteins, in Cattle
doi 10.17352/jvi.000001
Full Text
Open PDF
Abstract
Available in
full text
Date
April 21, 2014
Authors
K Tabynov
Publisher
Peertechz Publications Private Limited
Related search
Construction, Expression and Purification of Brucella Spp. Recombinant Proteins L7/L12 and Sodc in E. Coli
Series of biological and medical
Field Evaluation of the Rough Mutant Brucella Abortus RB 51 Vaccine in Cattle
Journal of Veterinary Medical Research
Immunization of Mice With Recombinant Brucella Abortus Organic Hydroperoxide Resistance (Ohr) Protein Protects Against a Virulent Brucella Abortus 544 Infection
Journal of Microbiology and Biotechnology
Applied Microbiology
Biotechnology
Medicine
Brucella Melitensis Biovar 1 and Brucella Abortus S19 Vaccine Strain Infections in Milkers Working at Cattle Farms in the Khartoum Area, Sudan
PLoS ONE
Multidisciplinary
Evaluation of Recombinant Invasive, Non-Pathogenic Eschericia Coli as a Vaccine Vector Against the Intracellular Pathogen, Brucella
Journal of Immune Based Therapies and Vaccines
Enhancement of the Brucella AMOS PCR Assay for Differentiation of Brucella Abortus Vaccine Strains S19 and RB51.
Journal of Clinical Microbiology
Microbiology
Brucella Abortus Infection in Man
Australian Veterinary Journal
Medicine
Veterinary
Sulphonamide-P in Brucella Abortus Infection
BMJ
Aerosol Infection of BALB/c Mice With Brucella Melitensis and Brucella Abortus and Protective Efficacy Against Aerosol Challenge
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology